{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T16:13:16Z","timestamp":1779207196841,"version":"3.51.4"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T00:00:00Z","timestamp":1775347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82203516"],"award-info":[{"award-number":["82203516"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Changzhou Science and Technology Program","award":["CJ20220084"],"award-info":[{"award-number":["CJ20220084"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"DOI":"10.1186\/s13058-026-02246-3","type":"journal-article","created":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T20:44:09Z","timestamp":1775421849000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["TTPAL inhibits the progression of breast cancer and reprograms tumor-associated macrophages by inhibiting JAK2\/STAT3 signaling pathway"],"prefix":"10.1186","volume":"28","author":[{"given":"Lingfang","family":"Du","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanghua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,5]]},"reference":[{"issue":"1","key":"2246_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349. https:\/\/doi.org\/10.3322\/caac.21820.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2246_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0111-2","volume":"5","author":"N Harbeck","year":"2019","unstructured":"Harbeck N, Penault-Llorca F, Cortes J, Gnant M, Houssami N, Poortmans P, et al. Breast cancer. Nat Rev Dis Primers. 2019;5(1):66. https:\/\/doi.org\/10.1038\/s41572-019-0111-2.","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"2246_CR3","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.trecan.2017.09.001","volume":"3","author":"SK Yeo","year":"2017","unstructured":"Yeo SK, Guan J. Breast cancer: multiple subtypes within a tumor? Trends Cancer. 2017;3(11):753\u201360. https:\/\/doi.org\/10.1016\/j.trecan.2017.09.001.","journal-title":"Trends Cancer"},{"key":"2246_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2021.102286","volume":"100","author":"E Hamilton","year":"2021","unstructured":"Hamilton E, Shastry M, Shiller SM, Ren R. Targeting HER2 heterogeneity in breast cancer. Cancer Treat Rev. 2021;100:102286. https:\/\/doi.org\/10.1016\/j.ctrv.2021.102286.","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"2246_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02108-4","volume":"10","author":"X Xiong","year":"2025","unstructured":"Xiong X, Zheng L, Ding Y, Chen Y, Cai Y, Wang L, et al. Breast cancer: pathogenesis and treatments. Signal Transduct Target Ther. 2025;10(1):49. https:\/\/doi.org\/10.1038\/s41392-024-02108-4.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"2246_CR6","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.annonc.2024.10.824","volume":"36","author":"J Kim","year":"2025","unstructured":"Kim J, Munster PN. Estrogens and breast cancer. Ann Oncol. 2025;36(2):134\u201348. https:\/\/doi.org\/10.1016\/j.annonc.2024.10.824.","journal-title":"Ann Oncol"},{"issue":"1","key":"2246_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s40659-017-0140-9","volume":"50","author":"M Akram","year":"2017","unstructured":"Akram M, Iqbal M, Daniyal M, Khan AU. Awareness and current knowledge of breast cancer. Biol Res. 2017;50(1):33. https:\/\/doi.org\/10.1186\/s40659-017-0140-9.","journal-title":"Biol Res"},{"issue":"17","key":"2246_CR8","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1158\/0008-5472.CAN-23-3082","volume":"84","author":"G Lee","year":"2024","unstructured":"Lee G, Wong C, Cho A, West JJ, Crawford AJ, Russo GC, et al. E-cadherin induces serine synthesis to support progression and metastasis of breast cancer. Cancer Res. 2024;84(17):2820\u201335. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-3082.","journal-title":"Cancer Res"},{"issue":"1","key":"2246_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53023-9","volume":"15","author":"Y Gu","year":"2024","unstructured":"Gu Y, Taifour T, Bui T, Zuo D, Pacis A, Poirier A, et al. Osteopontin is a therapeutic target that drives breast cancer recurrence. Nat Commun. 2024;15(1):9174. https:\/\/doi.org\/10.1038\/s41467-024-53023-9.","journal-title":"Nat Commun"},{"issue":"1","key":"2246_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02165-x","volume":"23","author":"S Liu","year":"2024","unstructured":"Liu S, Zhang X, Wang W, Li X, Sun X, Zhao Y, et al. Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer. Mol Cancer. 2024;23(1):261. https:\/\/doi.org\/10.1186\/s12943-024-02165-x.","journal-title":"Mol Cancer"},{"issue":"11","key":"2246_CR11","first-page":"1339","volume":"81","author":"KL Maughan","year":"2010","unstructured":"Maughan KL, Lutterbie MA, Ham PS. Treatment of breast cancer. Am Fam Physician. 2010;81(11):1339\u201346.","journal-title":"Am Fam Physician"},{"issue":"8","key":"2246_CR12","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1038\/bjc.2014.429","volume":"111","author":"S Tuupanen","year":"2014","unstructured":"Tuupanen S, H\u00e4nninen UA, Kondelin J, von Nandelstadh P, Cajuso T, Gylfe AE, et al. Identification of 33 candidate oncogenes by screening for base-specific mutations. Br J Cancer. 2014;111(8):1657\u201362. https:\/\/doi.org\/10.1038\/bjc.2014.429.","journal-title":"Br J Cancer"},{"issue":"13","key":"2246_CR13","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1158\/0008-5472.CAN-18-2986","volume":"79","author":"H Gou","year":"2019","unstructured":"Gou H, Liang JQ, Zhang L, Chen H, Zhang Y, Li R, et al. Ttpal promotes colorectal tumorigenesis by stabilizing trip6 to activate wnt\/\u03b2-catenin signaling. Cancer Res. 2019;79(13):3332\u201346. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-2986.","journal-title":"Cancer Res"},{"issue":"49","key":"2246_CR14","doi-asserted-by":"publisher","first-page":"6666","DOI":"10.1038\/s41388-021-01838-x","volume":"40","author":"W Liu","year":"2021","unstructured":"Liu W, Gou H, Wang X, Li X, Hu X, Su H, et al. Ttpal promotes gastric tumorigenesis by directly targeting nnmt to activate pi3k\/akt signaling. Oncogene. 2021;40(49):6666\u201379. https:\/\/doi.org\/10.1038\/s41388-021-01838-x.","journal-title":"Oncogene"},{"key":"2246_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02378-8","volume":"24","author":"X Su","year":"2025","unstructured":"Su X, Yan X, Zhang H. The tumor microenvironment in hepatocellular carcinoma: mechanistic insights and therapeutic potential of traditional Chinese medicine. Mol Cancer. 2025;24:173. https:\/\/doi.org\/10.1186\/s12943-025-02378-8.","journal-title":"Mol Cancer"},{"issue":"6","key":"2246_CR16","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.7150\/thno.50928","volume":"11","author":"S Han","year":"2021","unstructured":"Han S, Wang W, Wang S, Yang T, Zhang G, Wang D, et al. Tumor microenvironment remodeling and tumor therapy based on m2-like tumor associated macrophage-targeting nano-complexes. Theranostics. 2021;11(6):2892\u2013916. https:\/\/doi.org\/10.7150\/thno.50928.","journal-title":"Theranostics"},{"key":"2246_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116930","volume":"177","author":"W Zhang","year":"2024","unstructured":"Zhang W, Wang M, Ji C, Liu X, Gu B, Dong T. Macrophage polarization in the tumor microenvironment: emerging roles and therapeutic potentials. Biomed Pharmacother. 2024;177:116930. https:\/\/doi.org\/10.1016\/j.biopha.2024.116930.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"2246_CR18","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.ccell.2025.03.015","volume":"43","author":"Y Zhu","year":"2025","unstructured":"Zhu Y, Zhou Z, Du X, Lin X, Liang Z, Chen S, et al. Cancer cell-derived arginine fuels polyamine biosynthesis in tumor-associated macrophages to promote immune evasion. Cancer Cell. 2025;43(6):1045\u201360. https:\/\/doi.org\/10.1016\/j.ccell.2025.03.015.","journal-title":"Cancer Cell"},{"issue":"2","key":"2246_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202406865","volume":"12","author":"L Song","year":"2025","unstructured":"Song L, Yu X, Wu Y, Zhang W, Zhang Y, Shao Y, et al. Integrin \u03b28 facilitates macrophage infiltration and polarization by regulating ccl5 to promote luad progression. Adv Sci. 2025;12(2):e2406865. https:\/\/doi.org\/10.1002\/advs.202406865.","journal-title":"Adv Sci"},{"issue":"8","key":"2246_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07020-x","volume":"15","author":"Z Meng","year":"2024","unstructured":"Meng Z, Zhang R, Wu X, Piao Z, Zhang M, Jin T. Lncrna haglros promotes breast cancer evolution through mir-135b-3p\/col10a1 axis and exosome-mediated macrophage m2 polarization. Cell Death Dis. 2024;15(8):633. https:\/\/doi.org\/10.1038\/s41419-024-07020-x.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2246_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-75922-z","volume":"14","author":"S Wu","year":"2024","unstructured":"Wu S, Guo F, Li M, Chen W, Jin L. Overexpression of slap2 inhibits triple-negative breast cancer progression by promoting macrophage M1-type polarization. Sci Rep. 2024;14(1):26035. https:\/\/doi.org\/10.1038\/s41598-024-75922-z.","journal-title":"Sci Rep"},{"key":"2246_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112365","volume":"136","author":"S Jin","year":"2024","unstructured":"Jin S, Liu W, He X, Zhang Y, Chen W, Wu Y, et al. Vista deficiency exerts anti-tumor effects in breast cancer through regulating macrophage polarization. Int Immunopharmacol. 2024;136:112365. https:\/\/doi.org\/10.1016\/j.intimp.2024.112365.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"2246_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2024.114148","volume":"440","author":"D Xu","year":"2024","unstructured":"Xu D, Zhang D, Wei W, Zhang C. Uba5 inhibition restricts lung adenocarcinoma via blocking macrophage M2 polarization and cisplatin resistance. Exp Cell Res. 2024;440(2):114148. https:\/\/doi.org\/10.1016\/j.yexcr.2024.114148.","journal-title":"Exp Cell Res"},{"issue":"2","key":"2246_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2022.166611","volume":"1869","author":"L Du","year":"2023","unstructured":"Du L, Dai B, Liu X, Zhou D, Yan H, Shen T, et al. Kdm6b regulates M2 polarization of macrophages by modulating the stability of nuclear \u03b2-catenin. Biochim Biophys Acta (BBA) \u2013 Mol Basis Disease. 2023;1869(2):166611. https:\/\/doi.org\/10.1016\/j.bbadis.2022.166611.","journal-title":"Biochim Biophys Acta (BBA) \u2013 Mol Basis Disease"},{"issue":"2","key":"2246_CR25","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41590-022-01398-6","volume":"24","author":"S Ma","year":"2023","unstructured":"Ma S, Sun B, Duan S, Han J, Barr T, Zhang J, et al. Ythdf2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8+ t cells. Nat Immunol. 2023;24(2):255\u201366. https:\/\/doi.org\/10.1038\/s41590-022-01398-6.","journal-title":"Nat Immunol"},{"issue":"4","key":"2246_CR26","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.prp.2009.11.006","volume":"206","author":"IB Pau Ni","year":"2010","unstructured":"Pau Ni IB, Zakaria Z, Muhammad R, Abdullah N, Ibrahim N, Aina Emran N, et al. Gene expression patterns distinguish breast carcinomas from normal breast tissues: the malaysian context. Pathol Res Pract. 2010;206(4):223\u20138. https:\/\/doi.org\/10.1016\/j.prp.2009.11.006.","journal-title":"Pathol Res Pract"},{"issue":"30","key":"2246_CR27","doi-asserted-by":"publisher","first-page":"4137","DOI":"10.1038\/s41388-018-0253-9","volume":"37","author":"J Chang","year":"2018","unstructured":"Chang J, Kuo W, Lin C, Chen W, Chan S, Chiu M, et al. Wild-type p53 upregulates an early onset breast cancer-associated gene gas7 to suppress metastasis via gas7\u2013cyfip1-mediated signaling pathway. Oncogene. 2018;37(30):4137\u201350. https:\/\/doi.org\/10.1038\/s41388-018-0253-9.","journal-title":"Oncogene"},{"issue":"2","key":"2246_CR28","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3892\/ijo.2012.1464","volume":"41","author":"Z Lian","year":"2012","unstructured":"Lian Z, Wang Q, Li W, Zhang A, Wu L. Screening of significantly hypermethylated genes in breast cancer using microarray-based methylated-cpg island recovery assay and identification of their expression levels. Int J Oncol. 2012;41(2):629\u201338. https:\/\/doi.org\/10.3892\/ijo.2012.1464.","journal-title":"Int J Oncol"},{"issue":"1","key":"2246_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-53695-0","volume":"9","author":"BM Boac","year":"2019","unstructured":"Boac BM, Abbasi F, Ismail-Khan R, Xiong Y, Siddique A, Park H, et al. Expression of the bad pathway is a marker of triple-negative status and poor outcome. Sci Rep. 2019;9(1):17496. https:\/\/doi.org\/10.1038\/s41598-019-53695-0.","journal-title":"Sci Rep"},{"issue":"7403","key":"2246_CR30","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10983","volume":"486","author":"C Curtis","year":"2012","unstructured":"Curtis C, Shah SP, Chin S, Turashvili G, Rueda OM, Dunning MJ, et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. 2012;486(7403):346\u201352. https:\/\/doi.org\/10.1038\/nature10983.","journal-title":"Nature"},{"issue":"23","key":"2246_CR31","doi-asserted-by":"publisher","first-page":"5734","DOI":"10.1111\/bph.70215","volume":"182","author":"M Posta","year":"2025","unstructured":"Posta M, Gy Rffy B. Pathway-level mutational signatures predict breast cancer outcomes and reveal therapeutic targets. Br J Pharmacol. 2025;182(23):5734\u201347. https:\/\/doi.org\/10.1111\/bph.70215.","journal-title":"Br J Pharmacol"},{"issue":"8016","key":"2246_CR32","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson J, Adler J, Dunger J, Evans R, Green T, Pritzel A, et al. Accurate structure prediction of biomolecular interactions with alphafold 3. Nature. 2024;630(8016):493\u2013500. https:\/\/doi.org\/10.1038\/s41586-024-07487-w.","journal-title":"Nature"},{"issue":"13","key":"2246_CR33","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, et al. Ucsf chimera\u2014a visualization system for exploratory research and analysis. J Comput Chem. 2004;25(13):1605\u201312. https:\/\/doi.org\/10.1002\/jcc.20084.","journal-title":"J Comput Chem"},{"issue":"10","key":"2246_CR34","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/cac2.12358","volume":"42","author":"R Hong","year":"2022","unstructured":"Hong R, Xu B. Breast cancer: an up-to-date review and future perspectives. Cancer Commun. 2022;42(10):913\u201336. https:\/\/doi.org\/10.1002\/cac2.12358.","journal-title":"Cancer Commun"},{"key":"2246_CR35","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.jare.2024.08.015","volume":"73","author":"M Xue","year":"2025","unstructured":"Xue M, Xu Z, Wang X, Chen J, Kong X, Zhou S, et al. Artemis: an independently validated prognostic prediction model of breast cancer incorporating epigenetic biomarkers with main effects and gene-gene interactions. J Adv Res. 2025;73:561\u201373. https:\/\/doi.org\/10.1016\/j.jare.2024.08.015.","journal-title":"J Adv Res"},{"issue":"10","key":"2246_CR36","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/s41571-024-00935-6","volume":"21","author":"MR Lloyd","year":"2024","unstructured":"Lloyd MR, Jhaveri K, Kalinsky K, Bardia A, Wander SA. Precision therapeutics and emerging strategies for hr-positive metastatic breast cancer. Nat Rev Clin Oncol. 2024;21(10):743\u201361. https:\/\/doi.org\/10.1038\/s41571-024-00935-6.","journal-title":"Nat Rev Clin Oncol"},{"issue":"8","key":"2246_CR37","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/s41568-024-00714-6","volume":"24","author":"MA Harris","year":"2024","unstructured":"Harris MA, Savas P, Virassamy B, O\u2019Malley MMR, Kay J, Mueller SN, et al. Towards targeting the breast cancer immune microenvironment. Nat Rev Cancer. 2024;24(8):554\u201377. https:\/\/doi.org\/10.1038\/s41568-024-00714-6.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2246_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4972","volume":"5","author":"H Jin","year":"2014","unstructured":"Jin H, Zhao JC, Wu L, Kim J, Yu J. Cooperativity and equilibrium with foxa1 define the androgen receptor transcriptional program. Nat Commun. 2014;5(1):3972. https:\/\/doi.org\/10.1038\/ncomms4972.","journal-title":"Nat Commun"},{"issue":"2","key":"2246_CR39","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/s41588-017-0034-3","volume":"50","author":"J Donaghey","year":"2018","unstructured":"Donaghey J, Thakurela S, Charlton J, Chen JS, Smith ZD, Gu H, et al. Genetic determinants and epigenetic effects of pioneer-factor occupancy. Nat Genet. 2018;50(2):250\u20138. https:\/\/doi.org\/10.1038\/s41588-017-0034-3.","journal-title":"Nat Genet"},{"issue":"11","key":"2246_CR40","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1038\/ng.3419","volume":"47","author":"MM Pomerantz","year":"2015","unstructured":"Pomerantz MM, Li F, Takeda DY, Lenci R, Chonkar A, Chabot M, et al. The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis. Nat Genet. 2015;47(11):1346\u201351. https:\/\/doi.org\/10.1038\/ng.3419.","journal-title":"Nat Genet"},{"issue":"7414","key":"2246_CR41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature11247","volume":"489","author":"Consortium TEP","year":"2012","unstructured":"Consortium TEP. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489(7414):57\u201374. https:\/\/doi.org\/10.1038\/nature11247.","journal-title":"Nature"},{"issue":"1","key":"2246_CR42","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41591-018-0262-9","volume":"25","author":"M Menotti","year":"2019","unstructured":"Menotti M, Ambrogio C, Cheong T, Pighi C, Mota I, Cassel SH, et al. Wiskott\u2013Aldrich syndrome protein (wasp) is a tumor suppressor in T cell lymphoma. Nat Med. 2019;25(1):130\u201340. https:\/\/doi.org\/10.1038\/s41591-018-0262-9.","journal-title":"Nat Med"},{"issue":"3","key":"2246_CR43","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1158\/2159-8290.CD-16-0653","volume":"7","author":"JS Zawistowski","year":"2017","unstructured":"Zawistowski JS, Bevill SM, Goulet DR, Stuhlmiller TJ, Beltran AS, Olivares-Quintero JF, et al. Enhancer remodeling during adaptive bypass to mek inhibition is attenuated by pharmacologic targeting of the P-TEFb complex. Cancer Discov. 2017;7(3):302\u201321. https:\/\/doi.org\/10.1158\/2159-8290.CD-16-0653.","journal-title":"Cancer Discov"},{"issue":"6159","key":"2246_CR44","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1126\/science.1242510","volume":"342","author":"M Kasowski","year":"2013","unstructured":"Kasowski M, Kyriazopoulou-Panagiotopoulou S, Grubert F, Zaugg JB, Kundaje A, Liu Y, et al. Extensive variation in chromatin states across humans. Science. 2013;342(6159):750\u20132. https:\/\/doi.org\/10.1126\/science.1242510.","journal-title":"Science"},{"issue":"1","key":"2246_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06418-1","volume":"23","author":"J Zhang","year":"2025","unstructured":"Zhang J, Xu Q, Sun G. Lipocalin-2 promotes NSCLC progression by activating the JAK2\/STAT3 signaling pathway. J Transl Med. 2025;23(1):419. https:\/\/doi.org\/10.1186\/s12967-025-06418-1.","journal-title":"J Transl Med"},{"issue":"1","key":"2246_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-025-03836-5","volume":"25","author":"Q Ma","year":"2025","unstructured":"Ma Q, Wang H, Zhao X, Gao X, Zhang Q, Liu Y, et al. Aurka promotes angiogenesis in uveal melanoma via activation of the JAK2\/STAT3\/VEGFA signaling pathway. Cancer Cell Int. 2025;25(1):207. https:\/\/doi.org\/10.1186\/s12935-025-03836-5.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"2246_CR47","doi-asserted-by":"publisher","first-page":"415","DOI":"10.7150\/ijbs.104311","volume":"21","author":"J Pan","year":"2025","unstructured":"Pan J, Zhang Y, Yao R, Yang M, Mao X, Song Z, et al. Igf1r enhances calcium oxalate monohydrate-induced epithelial-mesenchymal transition by reprogramming metabolism via the JAK2\/STAT3 signaling. Int J Biol Sci. 2025;21(1):415\u201332. https:\/\/doi.org\/10.7150\/ijbs.104311.","journal-title":"Int J Biol Sci"},{"key":"2246_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156356","volume":"137","author":"W Yu","year":"2025","unstructured":"Yu W, Chen S, Guan X, He G, Zhang W, Zhang H, et al. Yiqi huayu jiedu formula inhibits JAK2\/STAT3-mediated partial emt in treating chronic atrophic gastritis. Phytomedicine. 2025;137:156356. https:\/\/doi.org\/10.1016\/j.phymed.2024.156356.","journal-title":"Phytomedicine"},{"issue":"1","key":"2246_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-025-01235-0","volume":"31","author":"J Han","year":"2025","unstructured":"Han J, Rhee WJ, Shin J. Cytoplasmic hmgb1 promotes the activation of JAK2-STAT3 signaling and PD-L1 expression in breast cancer. Mol Med. 2025;31(1):197. https:\/\/doi.org\/10.1186\/s10020-025-01235-0.","journal-title":"Mol Med"},{"issue":"1","key":"2246_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07558-4","volume":"16","author":"Z Feng","year":"2025","unstructured":"Feng Z, Gao Y, Cai C, Tan J, Liu P, Chen Y, et al. Csf3r-as promotes hepatocellular carcinoma progression and sorafenib resistance through the csf3r\/JAK2\/STAT3 positive feedback loop. Cell Death Dis. 2025;16(1):217. https:\/\/doi.org\/10.1038\/s41419-025-07558-4.","journal-title":"Cell Death Dis"},{"issue":"8","key":"2246_CR51","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1038\/s41401-024-01258-z","volume":"45","author":"J Lai","year":"2024","unstructured":"Lai J, Zhao L, Hong C, Zou Q, Su J, Li S, et al. Baicalein triggers ferroptosis in colorectal cancer cells via blocking the JAK2\/STAT3\/GPX4 axis. Acta Pharmacol Sin. 2024;45(8):1715\u201326. https:\/\/doi.org\/10.1038\/s41401-024-01258-z.","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"2246_CR52","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2024.2432117","volume":"25","author":"M Gai","year":"2024","unstructured":"Gai M, Zhao L, Li H, Jin G, Li W, Wang F, et al. Lcp1 promotes ovarian cancer cell resistance to olaparib by activating the JAK2\/STAT3 signalling pathway. Cancer Biol Ther. 2024;25(1):2432117. https:\/\/doi.org\/10.1080\/15384047.2024.2432117.","journal-title":"Cancer Biol Ther"},{"key":"2246_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.855351","volume":"13","author":"X Xiang","year":"2022","unstructured":"Xiang X, Ma H, Chen Y, Zhang D, Ma S, Wang H, et al. Gm-csf-mirna-JAK2\/STAT3 signaling mediates chemotherapy-induced cancer cell stemness in gastric cancer. Front Pharmacol. 2022;13:855351. https:\/\/doi.org\/10.3389\/fphar.2022.855351.","journal-title":"Front Pharmacol"},{"issue":"1","key":"2246_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118998","volume":"338","author":"M Zhou","year":"2025","unstructured":"Zhou M, Niu H, Lu D, Zhang H, Luo D, Yu Z, et al. Wu mei wan suppresses colorectal cancer stemness by regulating sox9 expression via JAK2\/STAT3 pathway. J Ethnopharmacol. 2025;338(1):118998. https:\/\/doi.org\/10.1016\/j.jep.2024.118998.","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"2246_CR55","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.70092","volume":"39","author":"X Fang","year":"2025","unstructured":"Fang X, Wen X, Hou Y, Zhou L, Jiang Y, Chen Y. Lmod1 exerts a tumor-suppressive role in breast cancer by restraining the JAK2\/STAT3 pathway. J Biochem Mol Toxicol. 2025;39(1):e70092. https:\/\/doi.org\/10.1002\/jbt.70092.","journal-title":"J Biochem Mol Toxicol"},{"issue":"3","key":"2246_CR56","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1136\/gutjnl-2024-333617","volume":"74","author":"Y Li","year":"2025","unstructured":"Li Y, Zheng Y, Huang J, Nie R, Wu Q, Zuo Z, et al. Caf-macrophage crosstalk in tumour microenvironments governs the response to immune checkpoint blockade in gastric cancer peritoneal metastases. Gut. 2025;74(3):350\u201363. https:\/\/doi.org\/10.1136\/gutjnl-2024-333617.","journal-title":"Gut"},{"issue":"2","key":"2246_CR57","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s43018-025-00909-2","volume":"6","author":"R Jin","year":"2025","unstructured":"Jin R, Neufeld L, McGaha TL. Linking macrophage metabolism to function in the tumor microenvironment. Nat Cancer. 2025;6(2):239\u201352. https:\/\/doi.org\/10.1038\/s43018-025-00909-2.","journal-title":"Nat Cancer"},{"issue":"2","key":"2246_CR58","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.cell.2024.10.042","volume":"188","author":"L Onder","year":"2025","unstructured":"Onder L, Papadopoulou C, L\u00fctge A, Cheng H, L\u00fctge M, Perez-Shibayama C, et al. Fibroblastic reticular cells generate protective intratumoral t cell environments in lung cancer. Cell. 2025;188(2):430\u201346. https:\/\/doi.org\/10.1016\/j.cell.2024.10.042.","journal-title":"Cell"},{"issue":"1","key":"2246_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-024-01618-6","volume":"17","author":"X Wang","year":"2024","unstructured":"Wang X, Chai Y, Quan Y, Wang J, Song J, Zhou W, et al. Npm1 inhibits tumoral antigen presentation to promote immune evasion and tumor progression. J Hematol Oncol. 2024;17(1):97. https:\/\/doi.org\/10.1186\/s13045-024-01618-6.","journal-title":"J Hematol Oncol"},{"key":"2246_CR60","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-24-0791","author":"S Mei","year":"2025","unstructured":"Mei S, Zhang H, Hirz T, Jeffries NE, Xu Y, Baryawno N, et al. Single-cell and spatial transcriptomics reveal a tumor-associated macrophage subpopulation that mediates prostate cancer progression and metastasis. Mol Cancer Res. 2025. https:\/\/doi.org\/10.1158\/1541-7786.MCR-24-0791.","journal-title":"Mol Cancer Res"},{"issue":"10","key":"2246_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07123-5","volume":"15","author":"B Yang","year":"2024","unstructured":"Yang B, Li G, Wang S, Zheng Y, Zhang J, Pan B, et al. Tumor-associated macrophages\/c-x-c motif chemokine ligand 1 promotes breast cancer autophagy-mediated chemoresistance via igf1r\/stat3\/hmgb1 signaling. Cell Death Dis. 2024;15(10):743. https:\/\/doi.org\/10.1038\/s41419-024-07123-5.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2246_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-025-03321-x","volume":"44","author":"S Dong","year":"2025","unstructured":"Dong S, Li X, Chen Z, Shi H, Wang Z, Zhou W. Mmp28 recruits m2-type tumor-associated macrophages through mapk\/jnk signaling pathway-dependent cytokine secretion to promote the malignant progression of pancreatic cancer. J Exp Clin Cancer Res: CR. 2025;44(1):60. https:\/\/doi.org\/10.1186\/s13046-025-03321-x.","journal-title":"J Exp Clin Cancer Res: CR"},{"issue":"1","key":"2246_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02183-9","volume":"23","author":"H Wang","year":"2024","unstructured":"Wang H, Wang T, Yan S, Tang J, Zhang Y, Wang L, et al. Crosstalk of pyroptosis and cytokine in the tumor microenvironment: from mechanisms to clinical implication. Mol Cancer. 2024;23(1):268. https:\/\/doi.org\/10.1186\/s12943-024-02183-9.","journal-title":"Mol Cancer"},{"issue":"8","key":"2246_CR64","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.472","volume":"11","author":"J Chen","year":"2021","unstructured":"Chen J, Wang Y, Zhang W, Zhao D, Zhang L, Zhang J, et al. Nox5 mediates the crosstalk between tumor cells and cancer-associated fibroblasts via regulating cytokine network. Clin Transl Med. 2021;11(8):472. https:\/\/doi.org\/10.1002\/ctm2.472.","journal-title":"Clin Transl Med"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-026-02246-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02246-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02246-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T15:51:12Z","timestamp":1779205872000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13058-026-02246-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,5]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2246"],"URL":"https:\/\/doi.org\/10.1186\/s13058-026-02246-3","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,5]]},"assertion":[{"value":"31 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval (2025(ke)-No.111) and prior patient consents were obtained from the Ethics Committee of Changzhou First People's Hospital to use the clinical specimens for research purposes. Animal experimental procedures were approved by the Institutional Animal Care and Use Committee of Jiangsu Agrochem Laboratory (IACUC-2024\u2013014). According to the guidelines (GB\/T35892-2018), the ethics committee specified that the maximal tumor burden is no more than 10% of the body weight of animals and the average diameter is less than 20\u00a0mm. During the experiment, the tumor sizes of the mice complied with the regulations. The study complied with the principles set out in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Informed consent was obtained from the patients for use of their data for experimentation.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"96"}}